Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (151-160 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|January 15, 1999
[How I study a patient with a low concentration of HDL cholesterol]A J Scheen
Revue Medicale De Liege|December 19, 1998
[Pharma-clinics. Drug of the month. Premelle (conjugated estrogens + medroxyprogesterone]A J Scheen
Revue Medicale De Liege|November 12, 1998
[Therapeutic update 1997-1998 (1). First part]A J Scheen
Acta Clinica Belgica|January 1, 1996
Lessons from the discovery of leptin: is obesity an endocrine disease?A J Scheen
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of metforminA J Scheen
Journal of Neuroendocrinology|May 9, 2008
CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabantA J Scheen
Revue Medicale De Liege|March 19, 1999
[Hypercholesterolemia-related cardiovascular risk: a continuum from a notion of normality, intervention threshold and therapeutic objectives]A J Scheen
Revue Medicale De Liege|March 19, 1999
[Pharma-clinics. The drug of the month. Aceclofenac (Biofenac)]A J Scheen
Revue Medicale De Liege|July 26, 2000
[Evidence-based medicine. Input of controlled clinical trials]A J Scheen
Revue Medicale De Liege|July 26, 2000
[On the inapplicability of certain therapeutic guidelines in practice: the example of reimbursement for hypolipidemic agents in Belgium]A J Scheen
Pageof 79

Showing results (151-160 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|January 15, 1999
[How I study a patient with a low concentration of HDL cholesterol]A J Scheen
Revue Medicale De Liege|December 19, 1998
[Pharma-clinics. Drug of the month. Premelle (conjugated estrogens + medroxyprogesterone]A J Scheen
Revue Medicale De Liege|November 12, 1998
[Therapeutic update 1997-1998 (1). First part]A J Scheen
Acta Clinica Belgica|January 1, 1996
Lessons from the discovery of leptin: is obesity an endocrine disease?A J Scheen
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of metforminA J Scheen
Journal of Neuroendocrinology|May 9, 2008
CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabantA J Scheen
Revue Medicale De Liege|March 19, 1999
[Hypercholesterolemia-related cardiovascular risk: a continuum from a notion of normality, intervention threshold and therapeutic objectives]A J Scheen
Revue Medicale De Liege|March 19, 1999
[Pharma-clinics. The drug of the month. Aceclofenac (Biofenac)]A J Scheen
Revue Medicale De Liege|July 26, 2000
[Evidence-based medicine. Input of controlled clinical trials]A J Scheen
Revue Medicale De Liege|July 26, 2000
[On the inapplicability of certain therapeutic guidelines in practice: the example of reimbursement for hypolipidemic agents in Belgium]A J Scheen
Pageof 79